Center for Bioelectronic Medicine

Nerve-stim startup Sanguistat shuffles its deck

By GREGORY ZELLER // A Connecticut-based biotech spun out of the Feinstein Institute for Medical Research has assembled a powerful collection of advisors and directors, including corporate heavyweights and recognized global leaders in the burgeoning field of biolelectronic medicine. Sanguistat Inc., a 2016 clinical-stage medical-device startup, has named Feinstein Institute President and CEO Kevin Tracey as chairman of its Scientific Advisory Board, a role that will leverage the pioneer’s decades of groundbreaking bioelectronics research. The…


Northwell innovators think outside the box, and in

By GREGORY ZELLER // Bioelectronics and “smart” tech won the day in the Northwell Health 2017 Innovation Challenge. The challenge, which invited the New Hyde Park-based health system’s 63,000-plus employees to submit groundbreaking healthcare ideas for a shot at project-development funding, eventually came down to two champions at Northwell Health’s Made For Big Ideas Showcase in October – a bioelectronic device designed to reduce premature births and a “smart” laboratory container that knows when a…


Knapp gift locks Feinstein bioelectronics on diabetes

By GREGORY ZELLER // A new research program will focus the Feinstein Institute for Medical Research’s considerable bioelectronic resources on a main antagonist of American health: diabetes. The research and development division of the Northwell Health system has received a $1 million gift from The Knapp Foundation, enough to kick off a four-year effort to explore bioelectronic medicine-based treatments for the chronic disease, which affects more than 29 million Americans – just under 10 percent…


Northwell, drug-maker ink bioelectronics partnership

By GREGORY ZELLER // Bioelectronic medicine has taken another forward leap, thanks to the Feinstein Institute for Medical Research’s latest professional alliance. The research-and-development arm of the Northwell Health system announced Thursday that it will apply its cutting-edge bioelectronics and cell-therapy technologies to cardiology and hypertension cases through a new “strategic partnership” with United Therapeutics Corp. Financial terms were not disclosed, but United Therapeutics will “fund Northwell’s efforts in four research-and-development tracks” while ushering new…


GE brings good things to bioelectronics research

By GREGORY ZELLER // General Electric is giving the Feinstein Institute for Medical Research a bioelectronic jolt. The Feinstein Institute, R&D mecca of the Northwell Health system, announced a new “strategic alliance” Tuesday with GE Ventures, the multinational conglomerate’s New Jersey-based business-licensing and equity arm. While no financial terms were disclosed, Northwell Health did note an “investment” that will help the Feinstein Institute’s evolving Center for Bioelectronic Medicine “continue its work in discovering, developing and…


Feinsteins donate $25M (again) to Northwell research

By GREGORY ZELLER // The Feinsteins have gone Bed, Bath & Beyond the call of duty, once again. Susan Feinstein and her husband, Leonard, co-founder and co-chairman of the New Jersey-based national housewares chain, announced Friday a fresh $25 million donation to Northwell Health’s Feinstein Institute for Medical Research – the health system’s busy Manhasset R&D hub, renamed in 2005 following the Feinsteins’ first $25 million gift. The new endowment will “further expand its research…